GENERAL HOSPITAL PSYCHIATRY综合医院精神医学
GENERAL HOSPITAL PSYCHIATRY(英文缩写 GEN HOSP PSYCHIAT),ISSN 0163-8343,eISSN 1873-7714,中文译名:综合医院精神医学 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。
发文量统计区间：2025-09-27 至 2026-09-27，按本站收录文献的发表日期统计。
期刊介绍
历年影响因子趋势
| JCR 数据年份 | 影响因子 | JCR 分区 |
|---|---|---|
| 2021 | 7.587 | Q1 |
| 2022 | 7.000 | Q1 |
| 2023 | 4.100 | Q1 |
| 2024 | 3.700 | Q1 |
| 2025 | 4.400 | Q1 |
GENERAL HOSPITAL PSYCHIATRY 最新收录文献
-
1. Frailty and clinical outcomes in older adults receiving consultation-liaison psychiatry: A multicentre prospective cohort study (OLD-3 Study).
PMID:日期:2026-09-21Older adults evaluated by consultation-liaison psychiatry services (CLPS) often present with complex psychiatric and medical comorbidity, frequent psychotropic exposure and a high prevalence of frailty. However, the relative contribution of these factors to clinical outcomes remains unclear. We conducted a multicentre prospective cohort study including 465 consecutive patients aged ≥65 years evaluated by CLPS in 10 general hospitals in Spain between January and July 2024. Psychiatric history, post-consultation psychiatric diagnoses, psychotropic use, age group (65-74 vs ≥75 years) and frailty assessed using the Clinical Frailty Scale were recorded. Outcomes included falls, institutionalization, access to mental health follow-up and mortality at 1 and 3 months after discharge. The mean (SD) age was 77.4 (7.8) years and 55.9% were women. Psychiatric history was present in 68.8% of patients and 55.8% received a new psychiatric diagnosis, most commonly delirium. Patients with falls also reported significantly higher levels of perceived loneliness. Psychotropic use was frequent (71.6%), particularly antidepressants (49.0%) and benzodiazepines (42.6%). Psychotropic polypharmacy was associated with falls. Frailty was prevalent (60.2%) and independently associated with early mortality, whereas age was the main predictor of mortality between 1 and 3 months. Older age was also associated with a lower likelihood of specialized mental health follow-up. Among older adults evaluated by CLPS, frailty and medical comorbidity appear to outweigh psychiatric variables in predicting outcomes. Integrating comprehensive geriatric assessment and medication review into CLPS may improve care for this population.
-
2. Dissociation in fibromyalgia: a systematic review with meta-analysis.
2. 纤维肌痛中的分离现象：一项系统综述与荟萃分析PMID:日期:2026-09-17Fibromyalgia (FM) is a complex chronic condition characterized by widespread pain and sensitivity to sensory stimuli, often associated with psychological comorbidities. Among these, dissociative symptoms (DS) - both psychological and somatoform - may play a role in symptom amplification. The aim of this review was to synthesize the available evidence on dissociative symptoms in FM, focusing on their severity, characteristics, and clinical correlates. Following the PRISMA guidelines, a comprehensive search was conducted on PubMed, Scopus, and Web of Science. The protocol was registered in PROSPERO. Thirteen studies met the inclusion criteria and were analyzed with regard to study design, sample characteristics, assessment tools, and key outcomes. A meta-analysis was conducted on a subgroup of nine case-control studies, using a multilevel mixed-effects model to estimate the combined effect size of DS in patients with FM compared to controls. Patients with FM showed higher levels of dissociation than healthy or clinical control groups. The meta-analysis revealed a significant, moderate-to-large combined effect (d = 0.743, 95% CI: 0.612-0.875, p < .001), with low heterogeneity. Somatoform dissociation emerged as particularly prevalent and was often linked to increased pain, psychological distress, and functional impairment. Childhood trauma, alexithymia, and emotional distress were often associated with DS. Dissociation, particularly somatoform dissociation, may be a clinically relevant but underestimated component in a subgroup of patients with FM.
-
3. Cancer-related pain and suicidal ideation in psychiatric outpatients with cancer: a cross-sectional study.
PMID:日期:2026-09-13To investigate the associations of pain severity and pain interference with both severity and intensity of suicidal ideation in a cohort of psychiatric outpatients with cancer. Psychiatric outpatients with cancer (n = 492) underwent a multidisciplinary assessment, including the Columbia-Suicide Severity Rating Scale (C-SSRS) to assess suicidal ideation severity and intensity, and the Brief Pain Inventory (BPI) to assess pain severity and pain interference. Additional validated measures were administered to assess depressive, anxiety, and manic symptoms. Univariate linear regression analyses were conducted to identify sociodemographic and clinical variables associated with suicidal ideation severity and intensity. Four multivariable linear regression models were then performed to investigate the association between pain and suicidal ideation dimensions, adjusting for significant covariates. In univariate analyses, family history of suicide, longer oncological illness, greater previous depressive episodes, greater depressive and manic symptomatology, and gastrointestinal cancer type were significantly associated with both suicidal ideation severity and intensity. In multivariable analyses, both pain severity and pain interference remained significantly associated with greater suicidal ideation intensity (pain severity: β = 0.32, p < 0.001; pain interference: β = 0.32, p < 0.001) and severity (pain severity: β = 0.10, p < 0.001; pain interference: β = 0.10, p < 0.001). These findings suggest that both the intensity of cancer-related pain and its impact on daily functioning are associated with suicidal ideation even after adjustment for major clinical and psychiatric covariates. Systematic pain assessment, coupled with targeted evaluation of suicide risk when needed, may help identify individuals requiring timely multidisciplinary care.
-
6. Effect of a structured psychological intervention on anxiety and depression symptoms in hospitalised patients following liver transplant on the general Ward.
PMID:日期:2026-09-01This study aimed to investigate the prevalence and associated factors of anxiety and depressive symptoms in patients after liver transplantation and to evaluate the effects of a structured psychological intervention. A total of 168 hospitalised patients who had undergone a liver transplant were enrolled after transfer from the intensive care unit (ICU) to the general ward, with stabilised vital signs. Anxiety and depressive symptoms and their influencing factors were assessed using the Hospital Anxiety and Depression Scale (HADS) and Perceived Social Support Scale (PSSS). Sixty-eight patients with both anxiety and depressive symptoms were randomised into an intervention group (routine care +12-day structured psychological intervention: daily 30-min progressive muscle relaxation training and psychological support every 3 days) and a control group (routine care only). Outcomes were reassessed post-intervention. Detection rates of anxiety and depressive symptoms were 37.5% and 32.1%, respectively. Independent factors for anxiety symptoms included sex, age, postoperative complications and social support; for depression symptoms, the factors were age, social support, length of stay, family support and financial pressure. After intervention, the intervention group showed significant reductions in HADS anxiety (13.2 ± 2.8 → 6.1 ± 3.2) and HADS depression (12.5 ± 3.1 → 5.8 ± 3.4) symptoms and an increase in PSSS (55.3 ± 12.1 → 67.8 ± 9.4) (all p < 0.001); no significant changes occurred in the control group. Post-intervention scores were significantly better in the intervention group than in the control group (all p < 0.01). Anxiety and depressive symptoms are highly prevalent after liver transplantation and are associated with multiple factors. Structured psychological intervention significantly improves symptoms and perceived social support, supporting its integration into routine post-transplant nursing care.
-
7. Pediatric catatonia across diagnostic contexts: Presentation, treatment course, and factors associated with ECT use.
PMID:日期:2026-09-01Objective Catatonia in young people is increasingly recognized, but pediatric cohorts remain limited. We characterized clinical presentation and treatment course and examined factors associated with electroconvulsive therapy (ECT) use and exploratory inflammatory correlates of psychomotor dimensions. Methods We retrospectively reviewed 57 consecutive patients aged <18 years treated at a tertiary referral center; one patient with a medical etiology was excluded from inferential analyses, leaving 56. DSM-5-TR signs were operationalized as hypokinetic, hyperkinetic, and parakinetic scores. Associations with ECT use were estimated using Firth penalized logistic regression. Admission neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), and systemic inflammation response index (SIRI) were examined with false-discovery-rate correction. Results Catatonia occurred across schizophrenia spectrum (n = 28), bipolar (11), depressive (11), and autism spectrum (6) disorders. ECT was used in 21 patients (37.5%). Older age, male sex, higher lorazepam-equivalent dose, and greater catatonia symptom burden were associated with ECT use. Each additional parakinetic sign was associated with higher odds of ECT use (OR 2.94, 95% CI 1.52-7.29), including after diagnostic-group adjustment; however, the parakinetic score overlapped substantially with total symptom burden, and their independent contributions could not be resolved. NLR and SIRI were associated only with the hyperkinetic score, which consisted of documented agitation. Thirty-five patients (62.5%) had a discharge CGI-catatonia score of 1. Conclusion ECT use was associated with greater catatonia symptom burden and higher parakinetic scores, but overlap between these measures and retrospective treatment selection preclude dimension-specific or causal inference. The laboratory findings were limited to agitation and require prospective confirmation.
-
8. Neurostimulants for disorders of consciousness in the intensive care unit: A systematic review.
PMID:日期:2026-08-29Disorders of consciousness (DoC; encompassing coma, unresponsive wakefulness syndrome, and minimally conscious state) are sequelae of critical illness that prolong hospitalization and interfere with engagement in care. Due to heterogeneous and incompletely understood pathophysiology, no pharmacologic standard of care has been established. We aimed to systematically examine the efficacy, safety, and dosing of neurostimulants among adult ICU patients with DoC. We conducted a systematic search of PubMed, Embase, CINAHL, and Web of Science from inception to December 2025. Studies that examined the use of neurostimulants for DoC in critically ill adults were included. We followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and used the Effective Public Health Practice Project framework to appraise bias. 35 studies met inclusion criteria: 11 randomized controlled trials, 19 observational, and 5 case-based studies. Amantadine was the most studied agent (N = 2743), with several studies reporting improvements in standardized measures of consciousness and earlier transition to rehabilitation. Modafinil (N = 1776) was primarily evaluated for hypersomnolence and demonstrated mixed effects on Glasgow Coma Scale (GCS) scores. Methylphenidate (N = 1044) demonstrated signals of benefit in both randomized studies and augmentation strategies with amantadine. Apomorphine was evaluated in one placebo-controlled ICU trial and carbidopa-levodopa in one case series. Despite inclusion in our search strategy, no studies examined caffeine, amphetamines, or bromocriptine. Neurostimulants were associated with short-term improvements in measures of arousal and recovery, although evidence remains heterogeneous and largely observational. Amantadine has the largest ICU evidence base; methylphenidate has been studied as monotherapy and augmentation; modafinil has primarily been evaluated for hypersomnolence. Further placebo-controlled trials are needed to establish efficacy across different causes of DoC; head-to-head studies are needed to clarify comparative effectiveness among available neurostimulants.
-
10. Psychedelic treatments and general hospital psychiatry: Emerging themes and future directions.
PMID:日期:2026-06-04该文献暂无摘要。